Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cervical cancer
Stage/Subtype:  stage III cervical cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-22 of 22 for your search:
Start Over
Intensity Modulated Radiation Therapy and Cisplatin in Treating Patients with Stage I-IVA Cervical Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 110808, NCI-2012-02858, NCT01554397
Cisplatin and Radiation Therapy with or without Lymphadenectomy in Treating Patients with Stage IB-IVA Cervical Cancer
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: 2010-0952, NCI-2011-02400, NCT01365156
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
Standard Radiation Therapy or Intensity-Modulated Pelvic Radiation Therapy in Treating Patients with Endometrial or Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 1203, NCI-2012-02001, CDR0000738944, NCT01672892
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CRAB CTC 11-001, NCI-2014-02260, CAR-IST-553, NCI-2013-02243, NCT01941316
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ME-344-002, NCI-2014-01013, NCT02100007
A Study of VGX-3100 and INO-9012 DNA Vaccine With Electroporation in Patients With Cervical Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: HPV-004, NCI-2015-00497, NCT02172911
Vaccine Therapy in Treating Patients with Persistent or Recurrent Cervical Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GOG-0265, NCI-2011-02671, CDR0000691288, NCT01266460
Cisplatin and Radiation Therapy in Treating Patients with HIV and Stage IB-IVA Cervical Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: AMC-081, NCI-2013-01314, NCT01590017
Tumor-Infiltrating Lymphocytes and High-Dose Aldesleukin after Combination Chemotherapy in Treating Patients with Metastatic or Locally Advanced Refractory Human Papilloma Virus-Associated Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-C-0116, NCI-2013-01524, 120116, 12C0116-H, 327146, P11943, NCT01585428
Eribulin Mesylate in Treating Patients with Advanced or Recurrent Cervical Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 5C-11-2, NCI-2012-01378, HS-11-00547, NCT01676818
Cisplatin and Radiation Therapy with or without Triapine in Treating Patients with Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 4812, NCI-2013-00804, NCI 9434, 9434, NCT01835171
Z-endoxifen Hydrochloride in Treating Patients with Refractory Hormone Receptor-Positive Breast Cancer, Desmoid Tumors, Gynecologic Tumors, or Other Hormone Receptor-Positive Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0061, NCI-2013-01475, 110061, P10725, 8826, NCT01273168
Intensity-Modulated Radiation Therapy, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Stage IB-IVA Cervical Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 100597, NCI-2012-02860, NCT01554410
Intensity-Modulated Radiation Therapy and Cisplatin in Treating Patients With Localized Gynecologic Cancer
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: Pro00033820, NCI-2013-00454, NCT01627288
Chemoradiation Therapy and Ipilimumab in Treating Patients with Locally Advanced Cervical Cancer
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GOG-9929, NCI-2012-01733, GOG-PIS1102, NCT01711515
HuMax®-TF-ADC Safety Study in Patients With Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GEN701, NCI-2014-01166, NCT02001623
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Phase: No phase specified
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, P08407, NCT00924027
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 01809, NCI-2009-01356, NCT01016561
Proton Beam Radiation Therapy in Treating Patients with Uterine and Cervical Cancer with Regional Lymph Node Metastases
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 10-269, NCI-2011-00894, NCT01600040
Start Over